2.0(top 20%)
impact factor
2.4K(top 10%)
papers
69.8K(top 5%)
citations
106(top 5%)
h-index
2.2(top 20%)
impact factor
3.1K
all documents
72.3K
doc citations
149(top 5%)
g-index
Top Articles
# | Title | Journal | Year | Citations |
---|---|---|---|---|
1 | THE EPIDEMIOLOGY OF RHEUMATOID ARTHRITIS | Rheumatic Disease Clinics of North America | 2001 | 568 |
2 | Epidemiology of Osteoarthritis | Rheumatic Disease Clinics of North America | 2013 | 484 |
3 | Corticosteroids | Rheumatic Disease Clinics of North America | 2016 | 436 |
4 | Epidemiology of Osteoarthritis | Rheumatic Disease Clinics of North America | 2008 | 397 |
5 | The Disease Activity Score and the EULAR Response Criteria | Rheumatic Disease Clinics of North America | 2009 | 380 |
6 | The Epidemiology of Psoriatic Arthritis | Rheumatic Disease Clinics of North America | 2015 | 354 |
7 | THE ROLE OF MUSCLE WEAKNESS IN THE PATHOGENESIS OF OSTEOARTHRITIS | Rheumatic Disease Clinics of North America | 1999 | 336 |
8 | Infection Risk and Safety of Corticosteroid Use | Rheumatic Disease Clinics of North America | 2016 | 307 |
9 | The Symptoms of Osteoarthritis and the Genesis of Pain | Rheumatic Disease Clinics of North America | 2008 | 295 |
10 | Epidemiology of Gout | Rheumatic Disease Clinics of North America | 2014 | 282 |
11 | PREGNANCY AND RHEUMATOID ARTHRITIS | Rheumatic Disease Clinics of North America | 1997 | 266 |
12 | Scleroderma epidemiology | Rheumatic Disease Clinics of North America | 2003 | 264 |
13 | Microfractures and microcracks in subchondral bone: are they relevant to osteoarthrosis? | Rheumatic Disease Clinics of North America | 2003 | 263 |
14 | THE CHINESE ANTI-INFLAMMATORY AND IMMUNOSUPPRESSIVE HERBAL REMEDY TRIPTERYGIUM WILFORDII HOOK F | Rheumatic Disease Clinics of North America | 2000 | 261 |
15 | Etiopathogenesis of Osteoarthritis | Rheumatic Disease Clinics of North America | 2008 | 253 |
16 | Lupus Activity in Pregnancy | Rheumatic Disease Clinics of North America | 2007 | 227 |
17 | Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria | Rheumatic Disease Clinics of North America | 2002 | 223 |
18 | Total Joint Arthroplasties: Current Concepts of Patient Outcomes after Surgery | Rheumatic Disease Clinics of North America | 2007 | 221 |
19 | SYSTEMIC SCLEROSIS | Rheumatic Disease Clinics of North America | 1996 | 215 |
20 | Pediatric Lupus—Are There Differences in Presentation, Genetics, Response to Therapy, and Damage Accrual Compared with Adult Lupus? | Rheumatic Disease Clinics of North America | 2010 | 214 |
21 | THE MECHANISM OF ACTION OF METHOTREXATE | Rheumatic Disease Clinics of North America | 1997 | 213 |
22 | Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being | Rheumatic Disease Clinics of North America | 2003 | 200 |
23 | Reactive Arthritis: Clinical Aspects and Medical Management | Rheumatic Disease Clinics of North America | 2009 | 186 |
24 | EPIDEMIOLOGY OF THE VASCULITIDES | Rheumatic Disease Clinics of North America | 2001 | 181 |
25 | Epidemiology of ANCA-associated Vasculitis | Rheumatic Disease Clinics of North America | 2010 | 180 |
26 | PATHOGENESIS OF SJÖGREN’S SYNDROME | Rheumatic Disease Clinics of North America | 1992 | 180 |
27 | INFECTION IN SYSTEMIC LUPUS ERYTHEMATOSUS | Rheumatic Disease Clinics of North America | 1998 | 178 |
28 | A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes | Rheumatic Disease Clinics of North America | 2017 | 178 |
29 | Epidemiology of Spondyloarthritis | Rheumatic Disease Clinics of North America | 2012 | 177 |
30 | RADIOLOGIC DIAGNOSIS AND PATHOLOGY OF THE SPONDYLOARTHROPATHIES | Rheumatic Disease Clinics of North America | 1998 | 173 |
31 | NUTRACEUTICALS AS THERAPEUTIC AGENTS IN OSTEOARTHRITIS | Rheumatic Disease Clinics of North America | 1999 | 173 |
32 | Scleroderma renal crisis | Rheumatic Disease Clinics of North America | 2003 | 171 |
33 | Bone Damage in Rheumatoid Arthritis: Mechanistic Insights and Approaches to Prevention | Rheumatic Disease Clinics of North America | 2010 | 169 |
34 | SALIVARY AND ORAL COMPONENTS OF SJÖGREN’S SYNDROME | Rheumatic Disease Clinics of North America | 1992 | 169 |
35 | Update on the Role of Muscle in the Genesis and Management of Knee Osteoarthritis | Rheumatic Disease Clinics of North America | 2013 | 164 |
36 | Juvenile Rheumatoid Arthritis: Outcome and Treatment for the 1990s | Rheumatic Disease Clinics of North America | 1991 | 163 |
37 | WHAT IS THE NATURAL HISTORY OF RHEUMATOID ARTHRITIS? | Rheumatic Disease Clinics of North America | 1993 | 163 |
38 | POPULATION GENETICS OF RHEUMATOID ARTHRITIS | Rheumatic Disease Clinics of North America | 1992 | 159 |
39 | PATHOGENESIS OF SCLERODERMA | Rheumatic Disease Clinics of North America | 1996 | 156 |
40 | Epidemiology of Osteoporosis | Rheumatic Disease Clinics of North America | 2006 | 156 |
41 | NEUROPSYCHIATRY LUPUS | Rheumatic Disease Clinics of North America | 1994 | 156 |
42 | PREMATURE ATHEROSCLEROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS | Rheumatic Disease Clinics of North America | 2000 | 154 |
43 | STRESS AND RHEUMATIC DISEASES | Rheumatic Disease Clinics of North America | 2000 | 154 |
44 | THE ROLE OF NITRIC OXIDE IN ARTICULAR CARTILAGE DAMAGE | Rheumatic Disease Clinics of North America | 1999 | 153 |
45 | THE NEUTROPHIL IN RHEUMATOID ARTHRITIS | Rheumatic Disease Clinics of North America | 1995 | 153 |
46 | Systemic lupus erythematosus in childhood | Rheumatic Disease Clinics of North America | 2002 | 152 |
47 | Fibromyalgia: The Clinical Syndrome | Rheumatic Disease Clinics of North America | 1989 | 152 |
48 | PLEUROPULMONARY MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS | Rheumatic Disease Clinics of North America | 1994 | 151 |
49 | Pyoderma Gangrenosum: An Update | Rheumatic Disease Clinics of North America | 2007 | 150 |
50 | ANKYLOSING SPONDYLITIS | Rheumatic Disease Clinics of North America | 1998 | 148 |